Rezurock (belumosudil)

pCPA File Number: 22595

Negotiation Status:

Under consideration for negotiation

Indication(s):

For the treatment of adult and pediatric patients 12 years and older with chronic graft-versus-host disease (GVHD) after failure of at least two prior lines of systemic therapy.

Sponsor/Manufacturer:

sanofi-aventis Canada Inc.

CADTH Project Number:

SR0789-000

pCPA Engagement Letter Issued:

Not Applicable

Negotiation Process Concluded:

Not Applicable